Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic accuracy of point-of-care ultrasound with artificial intelligence-assisted assessment of left ventricular ejection fraction.
Motazedian P, Marbach JA, Prosperi-Porta G, Parlow S, Di Santo P, Abdel-Razek O, Jung R, Bradford WB, Tsang M, Hyon M, Pacifici S, Mohanty S, Ramirez FD, Huggins GS, Simard T, Hon S, Hibbert B. Motazedian P, et al. Among authors: parlow s. NPJ Digit Med. 2023 Oct 28;6(1):201. doi: 10.1038/s41746-023-00945-1. NPJ Digit Med. 2023. PMID: 37898711 Free PMC article.
Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized Trial.
Jung RG, Di Santo P, Mathew R, Simard T, Parlow S, Weng W, Abdel-Razek O, Malhotra N, Cheung M, Hutson JH, Marbach JA, Motazedian P, Thibert MJ, Fernando SM, Nery PB, Nair GM, Russo JJ, Hibbert B, Ramirez FD. Jung RG, et al. Among authors: parlow s. Can J Cardiol. 2023 Apr;39(4):394-402. doi: 10.1016/j.cjca.2022.09.013. Epub 2022 Sep 20. Can J Cardiol. 2023. PMID: 36150583 Clinical Trial.
Efficacy of Milrinone and Dobutamine in Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis.
Abdel-Razek O, Di Santo P, Jung RG, Parlow S, Motazedian P, Prosperi-Porta G, Visintini S, Marbach JA, Ramirez FD, Simard T, Labinaz M, Mathew R, Hibbert B. Abdel-Razek O, et al. Among authors: parlow s. Crit Care Explor. 2023 Aug 28;5(9):e0962. doi: 10.1097/CCE.0000000000000962. eCollection 2023 Sep. Crit Care Explor. 2023. PMID: 37649849 Free PMC article. Review.
Methodological quality of COVID-19 clinical research.
Jung RG, Di Santo P, Clifford C, Prosperi-Porta G, Skanes S, Hung A, Parlow S, Visintini S, Ramirez FD, Simard T, Hibbert B. Jung RG, et al. Among authors: parlow s. Nat Commun. 2021 Feb 11;12(1):943. doi: 10.1038/s41467-021-21220-5. Nat Commun. 2021. PMID: 33574258 Free PMC article.
Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial.
Di Santo P, Mathew R, Jung RG, Simard T, Skanes S, Mao B, Ramirez FD, Marbach JA, Abdel-Razek O, Motazedian P, Parlow S, Boczar KE, D'Egidio G, Hawken S, Bernick J, Wells GA, Dick A, So DY, Glover C, Russo JJ, McGuinty C, Hibbert B; CAPITAL DOREMI investigators. Di Santo P, et al. Among authors: parlow s. Crit Care. 2021 Aug 10;25(1):289. doi: 10.1186/s13054-021-03706-2. Crit Care. 2021. PMID: 34376218 Free PMC article. Clinical Trial.
The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.
Parlow S, Di Santo P, Mathew R, Jung RG, Simard T, Gillmore T, Mao B, Abdel-Razek O, Ramirez FD, Marbach JA, Dick A, Glover C, Russo JJ, Froeschl M, Labinaz M, Fernando SM, Hibbert B; CAPITAL DOREMI investigators. Parlow S, et al. Eur Heart J Acute Cardiovasc Care. 2021 Oct 1;10(7):712-720. doi: 10.1093/ehjacc/zuab052. Eur Heart J Acute Cardiovasc Care. 2021. PMID: 34382063 Clinical Trial.
Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock.
Jung RG, Di Santo P, Mathew R, Abdel-Razek O, Parlow S, Simard T, Marbach JA, Gillmore T, Mao B, Bernick J, Theriault-Lauzier P, Fu A, Lau L, Motazedian P, Russo JJ, Labinaz M, Hibbert B. Jung RG, et al. Among authors: parlow s. J Am Heart Assoc. 2021 Nov 2;10(21):e021570. doi: 10.1161/JAHA.121.021570. Epub 2021 Oct 29. J Am Heart Assoc. 2021. PMID: 34713704 Free PMC article. Clinical Trial.
Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI Trial.
Parlow S, Weng W, Di Santo P, Jung RG, Lepage-Ratte MF, Motazedian P, Prosperi-Porta G, Abdel-Razek O, Simard T, Chan V, Labinaz M, Froeschl M, Mathew R, Hibbert B; CAPITAL DOREMI Investigators. Parlow S, et al. Can J Cardiol. 2022 Aug;38(8):1211-1219. doi: 10.1016/j.cjca.2022.04.004. Epub 2022 Apr 14. Can J Cardiol. 2022. PMID: 35430192 Clinical Trial.
No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trial.
Prosperi-Porta G, Motazedian P, Di Santo P, Jung RG, Parlow S, Abdel-Razek O, Simard T, Hutson J, Malhotra N, Fu A, Ramirez FD, Froeschl M, Mathew R, Hibbert B; CAPITAL DOREMI investigators. Prosperi-Porta G, et al. Among authors: parlow s. J Cardiol. 2022 Oct;80(4):358-364. doi: 10.1016/j.jjcc.2022.06.001. Epub 2022 Jun 17. J Cardiol. 2022. PMID: 35725945 Free article. Clinical Trial.
52 results